Alternatively, CD4+ T cell activation might permit persistent low-level infection of these cells, in turn maintaining efficient stimulation of the HIV-specific immune response [21], [43] and thereby helping to control viral replication through inducing CD38−/HLA-DR+ profile. The gene discussed is CD38; the disease is infection.